Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy

BACKGROUND: There is an urgent requirement to identify biomarkers to tailor treatment in human epidermal growth factor receptor 2 (HER2)–amplified early breast cancer treated with trastuzumab/pertuzumab-based chemotherapy. METHODS: Among the 225 patients randomly assigned to trastuzumab/pertuzumab c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Natl Cancer Inst
Auteurs principaux: Ignatiadis, Michail, Van den Eynden, Gert, Roberto, Salgado, Fornili, Marco, Bareche, Yacine, Desmedt, Christine, Rothé, Françoise, Maetens, Marion, Venet, David, Holgado, Esther, McNally, Virginia, Kiermaier, Astrid, Savage, Heidi M, Wilson, Timothy R, Cortes, Javier, Schneeweiss, Andreas, Willard-Gallo, Karen, Biganzoli, Elia, Sotiriou, Christos
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6335115/
https://ncbi.nlm.nih.gov/pubmed/29788230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy076
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires